A commentary on "Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study"
Int J Surg. 2024 Feb 21.
doi: 10.1097/JS9.0000000000001223.
Online ahead of print.
1 Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, China.
2 Department of Oncology,Fudan University Shanghai Cancer Center,Shanghai Medical College, Fudan University, Shanghai 200032, China.
3 School of Life Sciences, Fudan University, Shanghai 200438, China.
4 Department of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, 150000, Harbin, Heilongjiang, China.